Controls
Diasorin offers SimplexaTM Molecular and Process Controls for use in infectious disease molecular assays. SimplexaTM Process Controls are used to detect systemic variation that may arise during the extraction and amplification steps of real time PCR assays. SimplexaTM Molecular Controls are offered for a range of infectious disease targets.
Infectious disease
Product |
Descrizione |
Codice |
Volume/Quantity/Reactions |
|---|---|---|---|
| Simplexa™ adenovirus molecular control |
Consists of inactivated adenovirus. |
MOL8011 |
2 x 250 µL |
| Simplexa™ BKV molecular control |
Consists of a DNA fragment of a well conserved region of BKV VP2 gene. |
MOL8009 |
2 x 250 µL |
| Simplexa™ bordetella molecular control |
Consists of a 625 bp DNA fragment containing both the IS481 and IS1001 target regions. |
MOL8006 |
2 x 50 µL |
| Simplexa™ bordetella positive control pack |
Consists of inactivated Bordetella bacteria. |
MOL2760 |
10 |
| Simplexa™ C. difficile Positive Control Pack |
Consists of inactivated C. difficile bacteria. |
MOL2960 |
10 |
| Simplexa™ CMV Molecular Control |
Consists of a DNA fragment containing a well conserved region of CMV UL83 gene. |
MOL8002 |
2 x 250 µL |
| Simplexa™ Congenital CMV Positive Control Pack |
Consists of inactivated cytomegalovirus. |
MOL2260 |
10 |
| Simplexa™ COVID-19 & Flu A/B Positive Control Pack |
Consists of inactivated SARS-CoV-2 virus, inactivated influenza A virus and inactivated influenza B virus. |
MOL4260 |
10 |
| Simplexa™ COVID-19 Positive Control Pack |
Consists of synthetic gene fragments for SARS-CoV-2 ORF1ab and S gene target regions. |
MOL4160 |
10 |
| Simplexa™ Dengue Molecular Control |
Consists of inactivated Dengue virus including serotypes 1, 2, 3 and 4. |
MOL3103C |
2 x 800 µL |
| Simplexa™ EBV Molecular Control |
Consists of a DNA fragment of a well conserved region of EBV LMP2A gene. |
MOL8008 |
2 x 250 µL |
| Simplexa™ Flu A/B & RSV Positive Control Pack |
Consists of inactivated influenza A virus, inactivated influenza B virus, and inactivated RSV. |
MOL2660 |
10 |
| Simplexa™ GBS Positive Control Pack |
Consists of inactivated Group B Streptococcus bacteria. |
MOL3560 |
10 |
| Simplexa™ Group A Streptococcus Molecular Control |
Consists of inactivated Group A Streptococcus (GAS) bacteria. |
MOL8033 |
1 x 100 µL |
| Simplexa™ Group A Streptococcus Positive Control Pack |
Consists of inactivated Group A Streptococcus (GAS) bacteria. |
MOL2860 |
10 |
| Simplexa™ HSV 1 & 2 Positive Control Pack |
Consists of inactivated HSV 1 & 2 viruses. |
MOL2160 |
10 |
| Simplexa™ SARS-CoV-2 Variants Positive Control Pack (RUO) |
Consists of inactivated SARS-CoV-2 viral particles. For research use only. Not for use in diagnostic procedures. |
MOL4360 |
10 |
| Simplexa™ VZV Positive Control Pack |
Consists of inactivated varicella-zoster virus. |
MOL3660 |
10 |
| SimplexaTM Extraction and Amplification Control Set |
This set consists of a DNA template and labeled primer pair intended to be used as a process control to detect systemic variation that may arise during the extraction and amplification steps of real-time polymerase chain reaction (PCR) assays. The set is not intended to monitor other real-time PCR processes. |
MOL9000 MOL9300 |
100 1000 |
| Simplexa™ Extraction and Amplification Control Set – RNA |
This set consists of a RNA template and a labeled primer pair intended to be used as a process control to detect systemic variation that may arise during the extraction and amplification steps of real-time reverse transcription polymerase chain reaction (RT-PCR) assays. The set is not intended to monitor other real-time PCR processes. |
MOL9200 |
100 |